Harmony Biosciences announced today that the company has been certified by independent analysts as a Great Place to Work® for the third year in a row.
| PLYMOUTH MEETING, Pa., March 2, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, announced today that the company has been certified by independent analysts as a Great Place to Work® for the third year in a row. This certification is based on validated feedback from Harmony’s employees in an anonymous survey intended to determine exceptional workplace cultures.
“At Harmony, our team works hard each day to make a difference in the lives of patients and their families who live with rare neurological disorders,” said John C. Jacobs, President and CEO. “We are pleased to receive this honor for the third year and grateful that Harmony team members experience the company as a welcoming, caring and collaborative environment that aims to make a positive impact in the patient community.” Harmony’s employees completed survey questions regarding the credibility and competence of management, workplace culture, diversity and inclusion, sense of camaraderie, ethical business practices and available resources. A summary of these ratings is available at: https://www.greatplacetowork.com/certified-company/7011504. About Harmony Biosciences About Great Place to Work®
Harmony Biosciences Media Contact: Nancy Leone Harmony Biosciences Investor Contact: Lisa Caperelli
SOURCE Harmony Biosciences | ||
Company Codes: NASDAQ-NMS:HRMY |
View original content to download multimedia:
